APA

Cogle C. R., Collins B., Turner D., Pettiford L. C., Bossé R., Hawkins K. E., Beachamp Z., Wise E., Cline C., May W. S., Moreb J. S., Hsu J., Hiemenz J., Brown R., Norkin M., Wingard J. R. & Uckun F. (20210127). Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. : British journal of haematology.

Chicago

Cogle Christopher R, Collins Bradley, Turner Daniel, Pettiford Leslie C, Bossé Raphael, Hawkins Kimberly E, Beachamp Zackary, Wise Elizabeth, Cline Christina, May William S, Moreb Jan S, Hsu Jack, Hiemenz John, Brown Randall, Norkin Maxim, Wingard John R and Uckun Fatih. 20210127. Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. : British journal of haematology.

Harvard

Cogle C. R., Collins B., Turner D., Pettiford L. C., Bossé R., Hawkins K. E., Beachamp Z., Wise E., Cline C., May W. S., Moreb J. S., Hsu J., Hiemenz J., Brown R., Norkin M., Wingard J. R. and Uckun F. (20210127). Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. : British journal of haematology.

MLA

Cogle Christopher R, Collins Bradley, Turner Daniel, Pettiford Leslie C, Bossé Raphael, Hawkins Kimberly E, Beachamp Zackary, Wise Elizabeth, Cline Christina, May William S, Moreb Jan S, Hsu Jack, Hiemenz John, Brown Randall, Norkin Maxim, Wingard John R and Uckun Fatih. Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. : British journal of haematology. 20210127.